Presence of multiple recurrent mutations revealed by targeted NGS confers poor trial outcome of relapsed / refractory CLL
暂无分享，去创建一个
A. Pettitt | S. Knight | Jenny C. Taylor | A. Schuh | F. Davi | L. Ysebaert | V. Leblond | A. Burns | R. Clifford | A. Timbs | P. Combes | O. Tournilhac | F. Nguyen‐Khac | H. Merle-Béral | P. Robbe | J. Mason | M. Dilhuydy | L. Véronèse | A. Hamblin | P. Hillmen | M. Garff-Tavernier | R. Alsolami | S. Guibert | Bruno Pereira | M. Cabes | R. Guièze